BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10462325)

  • 1. Immune reactions in classical Hodgkin's lymphoma.
    Poppema S; Potters M; Emmens R; Visser L; van den Berg A
    Semin Hematol; 1999 Jul; 36(3):253-9. PubMed ID: 10462325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hodgkin's disease: biology can help the physician towards new prognostic factors and new therapeutic approaches].
    Rubio MT; Ghesquières H; Blay JY; Salles G
    Bull Cancer; 2001 Nov; 88(11):1081-90. PubMed ID: 11741802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: immunophenotypic and molecular studies.
    Chan WC
    Semin Hematol; 1999 Jul; 36(3):242-52. PubMed ID: 10462324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma.
    Enblad G; Molin D; Glimelius I; Fischer M; Nilsson G
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):805-23. PubMed ID: 17908621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-infiltrated immune response correlates with alterations in the apoptotic and cell cycle pathways in Hodgkin and Reed-Sternberg cells.
    Alvaro T; Lejeune M; García JF; Salvadó MT; López C; Bosch R; Jaén J; Escrivá P; Pons LE
    Clin Cancer Res; 2008 Feb; 14(3):685-91. PubMed ID: 18245527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between host T cells and Reed-Sternberg cells in Hodgkin lymphomas.
    Poppema S; van den Berg A
    Semin Cancer Biol; 2000 Oct; 10(5):345-50. PubMed ID: 11100882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin's disease: classification and differential diagnosis.
    Harris NL
    Mod Pathol; 1999 Feb; 12(2):159-75. PubMed ID: 10071341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment.
    Steidl C; Connors JM; Gascoyne RD
    J Clin Oncol; 2011 May; 29(14):1812-26. PubMed ID: 21483001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
    Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
    Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape.
    Aldinucci D; Gloghini A; Pinto A; De Filippi R; Carbone A
    J Pathol; 2010 Jul; 221(3):248-63. PubMed ID: 20527019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathology of Hodgkin's lymphoma].
    Hansmann ML; Willenbrock K
    Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin's lymphomas: classification, diagnosis, and grading.
    Harris NL
    Semin Hematol; 1999 Jul; 36(3):220-32. PubMed ID: 10462322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathogenesis of Hodgkin's lymphoma.
    Re D; Küppers R; Diehl V
    J Clin Oncol; 2005 Sep; 23(26):6379-86. PubMed ID: 16155023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.
    Asano N; Oshiro A; Matsuo K; Kagami Y; Ishida F; Suzuki R; Kinoshita T; Shimoyama Y; Tamaru J; Yoshino T; Kitamura K; Fukutani H; Morishima Y; Nakamura S
    J Clin Oncol; 2006 Oct; 24(28):4626-33. PubMed ID: 16954517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia.
    Hudnall SD; Betancourt E; Barnhart E; Patel J
    Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
    Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
    J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization.
    Hartmann S; Martin-Subero JI; Gesk S; Hüsken J; Giefing M; Nagel I; Riemke J; Chott A; Klapper W; Parrens M; Merlio JP; Küppers R; Bräuninger A; Siebert R; Hansmann ML
    Haematologica; 2008 Sep; 93(9):1318-26. PubMed ID: 18641027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodular lymphocyte predominant Hodgkin lymphoma.
    Lee AI; LaCasce AS
    Oncologist; 2009 Jul; 14(7):739-51. PubMed ID: 19605845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine.
    Fong D; Kaiser A; Spizzo G; Gastl G; Tzankov A
    Br J Haematol; 2005 Apr; 129(2):199-205. PubMed ID: 15813847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma.
    van den Berg A; Kroesen BJ; Kooistra K; de Jong D; Briggs J; Blokzijl T; Jacobs S; Kluiver J; Diepstra A; Maggio E; Poppema S
    Genes Chromosomes Cancer; 2003 May; 37(1):20-8. PubMed ID: 12661002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.